ATE496031T1 - ARYLOXYETHYLAMINE COMPOUNDS SUITABLE FOR THE TREATMENT OF DISEASES RESPONSIBLE TO MODULATION OF THE DOPAMINE D3 RECEPTOR - Google Patents
ARYLOXYETHYLAMINE COMPOUNDS SUITABLE FOR THE TREATMENT OF DISEASES RESPONSIBLE TO MODULATION OF THE DOPAMINE D3 RECEPTORInfo
- Publication number
- ATE496031T1 ATE496031T1 AT07728098T AT07728098T ATE496031T1 AT E496031 T1 ATE496031 T1 AT E496031T1 AT 07728098 T AT07728098 T AT 07728098T AT 07728098 T AT07728098 T AT 07728098T AT E496031 T1 ATE496031 T1 AT E496031T1
- Authority
- AT
- Austria
- Prior art keywords
- treatment
- dopamine
- receptor
- modulation
- compounds suitable
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Hydrogenated Pyridines (AREA)
Abstract
The present invention relates to aryloxyethylamine compounds of the formula (I) and the physiologically tolerated acid addition salts thereof. The variables have the meanings given in the claims and the description. The invention also relates to the use of a compound of the formula (I) or a pharmaceutically acceptable salt thereof for preparing a pharmaceutical composition for the treatment of a medical disorder susceptible to treatment with a dopamine D3 receptor ligand.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP06007923 | 2006-04-14 | ||
US79367106P | 2006-04-20 | 2006-04-20 | |
PCT/EP2007/053633 WO2007118859A1 (en) | 2006-04-14 | 2007-04-13 | Aryloxyethylamine compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE496031T1 true ATE496031T1 (en) | 2011-02-15 |
Family
ID=40631425
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT07728098T ATE496031T1 (en) | 2006-04-14 | 2007-04-13 | ARYLOXYETHYLAMINE COMPOUNDS SUITABLE FOR THE TREATMENT OF DISEASES RESPONSIBLE TO MODULATION OF THE DOPAMINE D3 RECEPTOR |
Country Status (6)
Country | Link |
---|---|
CN (1) | CN101421243B (en) |
AT (1) | ATE496031T1 (en) |
DE (1) | DE602007012071D1 (en) |
ES (1) | ES2360254T3 (en) |
PE (1) | PE20080057A1 (en) |
TW (1) | TWI400233B (en) |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW450954B (en) * | 1998-05-14 | 2001-08-21 | Pharmacia & Amp Upjohn Company | Phenylsulfonamide-phenylethylamines useful as dopamine receptors |
AU2003218660A1 (en) * | 2002-02-13 | 2003-09-04 | Glaxo Group Limited | Benzenesulfonamide derivatives and their use as dopamine d3 and d2 receptor liga ds |
GB0411421D0 (en) * | 2004-05-21 | 2004-06-23 | Glaxo Group Ltd | Novel compounds |
-
2007
- 2007-04-13 PE PE2007000456A patent/PE20080057A1/en not_active Application Discontinuation
- 2007-04-13 AT AT07728098T patent/ATE496031T1/en not_active IP Right Cessation
- 2007-04-13 CN CN2007800134447A patent/CN101421243B/en not_active Expired - Fee Related
- 2007-04-13 ES ES07728098T patent/ES2360254T3/en active Active
- 2007-04-13 TW TW96113061A patent/TWI400233B/en not_active IP Right Cessation
- 2007-04-13 DE DE602007012071T patent/DE602007012071D1/en active Active
Also Published As
Publication number | Publication date |
---|---|
TWI400233B (en) | 2013-07-01 |
DE602007012071D1 (en) | 2011-03-03 |
ES2360254T3 (en) | 2011-06-02 |
CN101421243A (en) | 2009-04-29 |
PE20080057A1 (en) | 2008-03-10 |
TW200808727A (en) | 2008-02-16 |
CN101421243B (en) | 2012-05-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA201200318A1 (en) | Heterocyclic oximes | |
EA201290078A1 (en) | HETEROCYCLIC COMPOUNDS TO INHIBIT PASK | |
MY148258A (en) | Phenylamino-benzoxazole substituted carboxylic acids, method for their production and use thereof as medicaments | |
PT2150530E (en) | Substituted sulfonamide derivatives | |
UA109698C2 (en) | AZAINDASOL OR DIAZAINDASOL DERIVATIVES AS A MEDICINE | |
NZ600210A (en) | Substituted 4-aminocyclohexane derivatives | |
EA201200260A1 (en) | HETEROCYCLIC HYDRAZONES AND THEIR APPLICATION FOR THE TREATMENT OF CANCER AND INFLAMMATION | |
MX2008013212A (en) | 4-anilinoquinoline-3-carboxamides as csf-1r kinase inhibitors. | |
UA104489C2 (en) | Compounds for the treatment of dyslipidemia and related diseases | |
DOP2010000137A (en) | 1,2,3-TRIAZOL DERIVATIVES AS INHIBITORS FROM ESTEAROIL-COENZIMA TO DESATURASA | |
UA101393C2 (en) | COMPOSITIONS AND USE OF TRIAZOLE DERIVATIVES FOR TREATING β-AMYLOID DISEASES AND SYNUCLEINOPATHIES | |
EA201591957A1 (en) | GLUTARIMIDES DERIVATIVES, THEIR APPLICATION, PHARMACEUTICAL COMPOSITION ON THEIR BASIS, METHODS OF THEIR PRODUCTION | |
IN2012DN00953A (en) | ||
UY30284A1 (en) | APPROPRIATE ARYLOXYETHYLAMINE COMPOUNDS TO TREAT DISORDERS RESPONDING TO DOPAMINE D3 RECEPTOR MODULATION | |
ATE502008T1 (en) | AMINOMETHYL SUBSTITUTED BICYCLIC AROMATIC COMPOUNDS SUITABLE FOR THE TREATMENT OF DISEASES RESPONSIVE TO MODULATION OF THE DOPAMINE D3 RECEPTOR | |
MX2009013482A (en) | [1,10]-phenanthroline derivatives for the treatment of neurodegenerative or haematological diseases. | |
EA200870223A1 (en) | DERIVATIVES OF BENZOIZOINDOL FOR THE TREATMENT OF PAIN | |
SG10201809506TA (en) | Pharmaceutical compositions comprising 7-(1h-imidazol-4-ylmethyl)-5,6,7,8-tetrahydro-quinoline for treating skin diseases and conditions | |
DE602005001918D1 (en) | S-TENATOPRAZOLNATRIUM MONOHYDRATE SALT AND ITS USE IN THE FORM OF A PROTON PUMPING MASTER | |
ATE540922T1 (en) | AMINOETHYL AROMATIC COMPOUNDS SUITABLE FOR THE TREATMENT OF DISEASES RESPONSIVE TO MODULATION OF THE DOPAMINE D3 RECEPTOR | |
MY160005A (en) | 11-(2-pyrrolidin-1-yl-ethoxy)-14,19-dioxa-5,7,26-triaza-tetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene citrate salt | |
ATE496031T1 (en) | ARYLOXYETHYLAMINE COMPOUNDS SUITABLE FOR THE TREATMENT OF DISEASES RESPONSIBLE TO MODULATION OF THE DOPAMINE D3 RECEPTOR | |
EA201070478A1 (en) | DIPHENYL CARBONIC ACIDS AND THEIR DERIVATIVES | |
DOP2012000061A (en) | USE OF INDOL DERIVATIVES AS ACTIVATORS OF NURR-1, FOR THE APPLICATION IN TREATMENTS OF DISEASES AS PARKINSON | |
TW200635575A (en) | Use of substituted cyclopropane acid derivatives for producing medicaments for treating the metabolic syndrome |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |